{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:04:08Z","timestamp":1758636248670},"publisher-location":"Chichester, UK","reference-count":64,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001430.pub2","type":"reference-entry","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"source":"Crossref","is-referenced-by-count":17,"title":["Corticosteroids for treating optic neuritis"],"prefix":"10.1002","author":[{"given":"Satyanarayana S","family":"Vedula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Brodney Folse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin L","family":"Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD001430.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/jnnp.74.8.1139","article-title":"Corticosteroids do not prevent optic nerve atrophy following optic neuritis","volume":"74","author":"Hickman","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD001430.pub2-BIB2|cit2","first-page":"32","article-title":"Double-blind controlled trial of methylprednisolone treatment for acute optic neuritis: 6-month follow-up with visual evoked potential measurement","volume":"2 Suppl","author":"Jones","year":"1996","journal-title":"Multiple Sclerosis"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1212\/WNL.50.1.230","article-title":"Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis","volume":"50","author":"Kapoor","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB4|cit4","first-page":"30","article-title":"Optic neuritis treatment trial: Contrast sensitivity; assessment and results","volume":"15","author":"Tabuchi","year":"1998","journal-title":"Neuro-Ophthalmology Japan"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-5155(98)00071-9","article-title":"Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0021-5155(98)00072-0","article-title":"Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG)","volume":"43","author":"Wakakura","year":"1999","journal-title":"Japanese Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/archopht.1995.01100020014004","article-title":"The optic neuritis treatment trial: three-year follow-up results","volume":"113","author":"Beck","year":"1995","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub2-BIB11|cit8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archopht.1993.01090060061023","article-title":"Optic neuritis treatment trial. One year follow-up results","volume":"111","author":"Beck","year":"1993","journal-title":"Archives of Ophthalmology"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub2-BIB8|cit9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199202273260901","article-title":"A randomized controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group","volume":"326","author":"Beck","year":"1992","journal-title":"New England Journal Of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD001430.pub2-BIB9|cit10","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0161-6420(94)31103-1","article-title":"The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial","volume":"101","author":"Beck","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB10|cit11","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJM199312093292403","article-title":"The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis","volume":"24","author":"Beck","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0002-9394(03)00862-6","article-title":"Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"137","author":"Beck","year":"2004","journal-title":"American Journal of Ophthalmology"},{"issue":"16","key":"10.1002\/14651858.CD001430.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.1993.03500160080036","article-title":"Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial","volume":"269","author":"Chrousos","year":"1993","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD001430.pub2-BIB15|cit15","first-page":"1017","article-title":"The National Eye Institute Visual Function Questionnaire: Experience of the ONTT. The Optic Neuritis Treatment Trial","volume":"41","author":"Cole","year":"2000","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/archopht.1994.01090190094027","article-title":"Visual field profile of optic neuritis. One year follow-up in the Optic Neuritis Treatment Trial","volume":"112","author":"Keltner","year":"1994","journal-title":"Archives of Ophthalmology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD001430.pub2-BIB17|cit17","first-page":"61","article-title":"Corticosteroids for optic neuritis ans subsequent development of multiple sclerosis","volume":"120","author":"Noseworthy","year":"1994","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/WNL.49.5.1404","article-title":"The 5-year risk of MS after optic neuritis: Experience of the optic neuritis treatment trial","volume":"49","year":"1997","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD001430.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archopht.1997.01100160715008","article-title":"Visual function 5 years after optic neuritis: Experience of the Optic Neuritis Treatment Trial","volume":"115","year":"1997","journal-title":"Archives of Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB20|cit20","first-page":"A280","article-title":"One-year results in the optic neuritis treatment trial","volume":"43","author":"Trobe","year":"1993","journal-title":"Neurology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD001430.pub2-BIB21|cit21","first-page":"Abstract no. 7-","article-title":"A double-blind randomized study of oral prednisolone versus placebo in patients with acute optic neuritis","volume":"20","author":"Frederiksen","year":"1993","journal-title":"Canadian Journal of Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1191\/1352458503ms880sr","article-title":"Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis","volume":"9","author":"Sellbjerg","year":"2003","journal-title":"Multiple Sclerosis"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1468-1331.2000.00074.x","article-title":"Immunological effects of oral high-dose methylprednisolone in acute optic neuritis and multiple sclerosis","volume":"7","author":"Sellebjerg","year":"2000","journal-title":"European Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1212\/WNL.52.7.1479","article-title":"A randomized, controlled trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"52","author":"Sellebjerg","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB25|cit25","first-page":"381","article-title":"A placebo-controlled treatment trial of oral high-dose methylprednisolone in acute optic neuritis","volume":"4","author":"Sellebjerg","year":"1998","journal-title":"Multiple Sclerosis"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub2-BIB29|cit26","first-page":"415","article-title":"The Aulhorn flicker test: possibilities and limits. Its use in optic neuritis for diagnosis, differential diagnosis, monitoring the course of the disease, and assessing the effect of oral prednisolone","volume":"1","author":"Trauzettel-Klosinski","year":"1992","journal-title":"German Journal of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB26|cit27","first-page":"490","article-title":"[The influence of prednisolone on the course of optic neuritis. Results of a double-blind study]","volume":"88","author":"Trauzettel-Klosinski","year":"1991","journal-title":"Fortschritte Der Ophthalmologie"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub2-BIB27|cit28","first-page":"385","article-title":"The Tubingen study on optic neuritis treatment - A prospective, randomized and controlled trial","volume":"8","author":"Trauzettel-Klosinski","year":"1993","journal-title":"Clinical Vision Sciences"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB28|cit29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01203696","article-title":"The effect of oral prednisolone on visual evoked potential latencies in acute optic neuritis monitored in a prospective, randomized, controlled study","volume":"91","author":"Trauzettel-Klosinski","year":"1996","journal-title":"Documenta Ophthalmologica"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub2-BIB30|cit30","first-page":"227","article-title":"[Comparative treatment of acute optic neuritis with \"boluses\" of intravenous methylprednisolone or oral prednisone","volume":"130","author":"Alejandro","year":"1994","journal-title":"Gaceta Medica de Mexico"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB31|cit31","first-page":"372","article-title":"[Comparison of stimulation therapy with glucocorticoid therapy in optic nerve inflammation]","volume":"29","author":"Beran","year":"1973","journal-title":"Ceskoslovenska Oftalmologie"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.optm.2005.07.003","article-title":"Acute inflammatory demyelinating optic neuritis: current concepts in diagnosis and management","volume":"76","author":"Bhatti","year":"2005","journal-title":"Optometry"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub2-BIB33|cit33","first-page":"412","article-title":"Treatment of acute optic neuritis","volume":"96","author":"Bird","year":"1976","journal-title":"Transactions of the Ophthalmological Societies of the United Kingdom"},{"key":"10.1002\/14651858.CD001430.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jnnp.37.8.869","article-title":"A trial of conticotrophin gelatin injection in acute optic neuritis","volume":"37","author":"Bowden","year":"1974","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s004150050454","article-title":"Long-term recovery and fellow eye deterioration after optic neuritis, determined by serial visual evoked potentials","volume":"246","author":"Brusa","year":"1999","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00041327-200406000-00013","article-title":"41st Annual Meeting of the Japanese Neuro-Ophthalmology Society, Kyoto, Japan, December 12-13, 2003","volume":"24","author":"Chuman","year":"2004","journal-title":"Journal of Neuro-Ophthalmology"},{"issue":"6075","key":"10.1002\/14651858.CD001430.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.1.6075.1495","article-title":"Treatmenf of optic neuritis by retrobulbar injection of triamcinolone","volume":"1","author":"Gould","year":"1977","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB39|cit39","first-page":"30","article-title":"Progress of optic neuritis with and without corticosteroid treatment","volume":"80","author":"Hallermann","year":"1983","journal-title":"Fortschritte der Ophthalmologie"},{"key":"10.1002\/14651858.CD001430.pub2-BIB40|cit40","unstructured":"Hick Man S NOON. Nitric oxide in optic neuritis: A phase I randomised double-blind study of rapid corticosteroid treatment of optic neuritis National Research Register, UK 2002"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0039-6257(94)90201-1","article-title":"The Tubingen Study on Optic Neuritis Treatment - a prospective, randomized and controlled trial","volume":"39","author":"Katz","year":"1994","journal-title":"Survey of Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB42|cit42","first-page":"S23","article-title":"Optic neuritis in multiple sclerosis patients treated with copaxone","volume":"244","author":"Kott","year":"1997","journal-title":"Journal of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD001430.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archneur.61.9.1401","article-title":"The natural history of recurrent optic neuritis","volume":"61","author":"Pirko","year":"2004","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0140-6736(66)92025-3","article-title":"Treatment of acute retrobulbar neuritis with corticotrophin.","volume":"2","author":"Rawson","year":"1966","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001430.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(69)91469-X","article-title":"Treatment of retrobulbar neuritis with corticotropin","volume":"2","author":"Rawson","year":"1969","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","article-title":"A double-blind randomized trial of IV immunoglobulin treatment in acute optic neuritis","volume":"64","author":"Roed","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB47|cit47","first-page":"122","article-title":"[Treatment of acute optic neuritis with large doses of corticosteroids]","volume":"97","author":"Toczolowski","year":"1995","journal-title":"Klinika Oczna"},{"key":"10.1002\/14651858.CD001430.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","article-title":"Contrast sensitivity and other vision tests in the optic neuritis treatment trial","volume":"121","author":"Trobe","year":"1996","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD001430.pub2-BIB49|cit49","first-page":"126","article-title":"Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)","volume":"205","author":"Kommerell","year":"1994","journal-title":"Klinische Monatsblatter Fur Augenheilkunde"},{"issue":"4","key":"10.1002\/14651858.CD001430.pub2-BIB50|cit50","first-page":"425","article-title":"Optic neuritis: Diagnosis, treatment and follow-up","volume":"125","author":"Midgard","year":"2005","journal-title":"Tidsskrift for Den Norske Laegeforening"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB51|cit51","first-page":"387","article-title":"Corticosteroids and acute optic nerve neuritis. A therapeutic method requiring further studies","volume":"92","author":"Soderstrom","year":"1995","journal-title":"Lakartidningen"},{"key":"10.1002\/14651858.CD001430.pub2-BIB52|cit52","first-page":"599","article-title":"Optic Neuritis","volume-title":"Walsh and Hoyt's Neuro-ophthalmology","author":"Beck","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD001430.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004150070172","article-title":"Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials","volume":"247","author":"Brusaferri","year":"2000","journal-title":"Journal of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archneur.1985.04060070096025","article-title":"Optic neuritis and multiple sclerosis","volume":"42","author":"Ebers","year":"1985","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD001430.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0161-6420(87)33349-4","article-title":"Deficits in visual function after resolution of optic neuritis","volume":"94","author":"Fleishman","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD001430.pub2-BIB56|cit56","article-title":"Locating and selecting studies. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. Section 5","volume-title":"The Cochrane Library, Issue 3, 2005","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD001430.pub2-BIB57|cit57","article-title":"Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]","volume-title":"The Cochrane Library, Issue 3, 2005","author":"Higgins","year":"2005"},{"issue":"13","key":"10.1002\/14651858.CD001430.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD001430.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0404.1988.tb03672.x","article-title":"Epidemiology of multiple sclerosis: incidence and prevalence rates in Denmark 1948-64 based on the Danish Multiple Sclerosis Registry","volume":"78","author":"Koch-Henriksen","year":"1988","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD001430.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archneur.1985.04060070098026","article-title":"Optic neuritis or multiple sclerosis","volume":"42","author":"Kurtzke","year":"1985","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD001430.pub2-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1001\/archopht.116.11.1496","article-title":"Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators","volume":"116","author":"Mangione","year":"1998","journal-title":"Archives of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD001430.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.45.2.244","article-title":"Optic neuritis: a population-based study in Olmsted County, Minnesota","volume":"45","author":"Rodriguez","year":"1995","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD001430.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/bjo.70.12.918","article-title":"Estimation of visual function after optic neuritis: a comparison of clinical tests","volume":"70","author":"Sanders","year":"1986","journal-title":"British Journal of Ophthalmology"},{"issue":"1","key":"10.1002\/14651858.CD001430.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0161-6420(88)33220-3","article-title":"Treatment of optic neuritis with intravenous megadose corticosteroids. A consecutive series","volume":"95","author":"Spoor","year":"1988","journal-title":"Ophthalmology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD001430.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:02:54Z","timestamp":1628542974000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001430.pub2"}},"subtitle":[],"editor":[{"given":"Robin L","family":"Gal","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":64,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001430.pub2","relation":{},"subject":[],"published":{"date-parts":[[2007,1,24]]}}}